Toxicological Risk Assessment

 

Toxicological Risk Assessment - Overview

Toxicological Risk Assessment (TRA) is a comprehensive safety-evaluation report for a specific ingredient or contaminant in the product. TRA is a detailed scientific assessment report prepared by an expert toxicologist based on sound scientific knowledge on the available information/data pertaining to the specific ingredient within the context of nature of the product, its dosage/concentration, and exposure scenario.

Freyr toxicologists, with their vast experience in toxicological risk assessment of pharmaceuticals, cosmetics, medical devices, food, and consumer products, have delivered numerous high quality TRA reports and non-clinical study report templates to many clients across the globe.

Toxicological Risk Assessment - Expertise

Pharmaceuticals
  • Safety evaluation and assessment of pharmaceutical excipients per the intended formulation and clinical usage.
  • Clinical exposure assessment, qualification, and Regulatory support for the DP/DS impurities.
  • Integrated safety evaluation and assessment of new drugs as part of drug discovery and development.
Medical Device
  • Biocompatibility safety assessment of medical devices per their intended surface contact and duration, based on ISO-10993.
  • Safety evaluation and Regulatory support for extractables and leachables.
Cosmetics
  • Human risk assessment and individual hazard assessment of flavors and fragrances.
  • Safety assessment of cosmetics and their individual ingredients.
Consumer Products
  • Toxicological risk assessment and exposures calculation for various consumer products viz, e-cigarettes, single, and multi-component ingredients, or mixtures.
Food
  • Assessing the hazards of natural compounds associated with food contamination.
  • Derivation of Health Criteria Values (HCVs) for substances present in food.
  • Recommending a Tolerable Daily Intake (TDI) for a contaminating pesticide.
  • Toxicological risk assessment of food-contact material migrants and derivation of oral TDIs.
General Chemicals
  • Complete safety reports for the chemicals per various regulations like the REACH.
  • The Globally Harmonized System’s (GHS’s) classification services.
  • Safety Data Sheet (SDS)/Material Safety Data Sheet (MSDS) services.
Toxicological Risk Assessment

Celebrating Customers Success

 

Medicinal Products

Regulatory Affairs

India

Thank you for the timely support over the weekend, which allowed us to resubmit quickly after being notified. This continuously demonstrates Freyr's commitment towards our company’s milestones.

Director - Global Regulatory Affairs – Operations

India-based, Global Top Generic Pharma Company

 

Medicinal Products

Publishing

UK

I am sure you have heard by now that we have received our first-ever approval from the FDA for our Brands division. This is a major milestone for us as well as for my team here in Reg Ops. I would be remiss if I didn’t point out that we would not have been able to do this without the help of your dedicated team. From the original filing, then the following year of responses, all helped get us to final approval.

Thank you Freyr team for a job well done!

Sr. Director, Head of Regulatory Operations

Ireland-based, Global Specialty Pharmaceutical Company

 

Medicinal Products

Regulatory Affairs

USA

Please relate to the team the excellent job they have done on the IND reactivation. Specifically, the high-quality module 3, written by Freyr. It was very comprehensive, very few revisions were required, and we had no questions from Health Canada or FDA. No CMC questions: that was a first for me. So very responsive to my many requests, which I am sure can be frustrating but always helpful while producing excellent work.

Thank you for always being available and responding quickly and comprehensively to all my requests.

What a great team you have, Freyr.

Lynne McGrath

Regulatory Consultant

 

Medicinal Products

Regulatory Affairs

USA

Congratulations!!! ​

Thanks for your great support for a successful ANDA filing, especially to the publishing team. Heartfully appreciate their last hours of hard work.

Assistant Manager​

US-based, Leading, Complex Generic Pharmaceutical Products Company​

 

Medicinal Products

Regulatory Affairs

USA

Thank you all for the great support!​

CEO

US-based, Leading Innovative Pharmaceuticals Company​

 

Medicinal Products

Regulatory Affairs

USA

The ANDA receipt has been received! Thank you very much for your hard work, patience, and support for our work over the last couple of months. We are delighted that we were able to meet the timeline and hit an important corporate goal of our young company. ​

Thank you again, and we look forward to working with your team on the next project!

Senior Director of Business and Product Development​

US-based, Leading Innovator Pharmaceuticals Company​